Excised Porcine Cornea Integrity Evaluation in an in vitro Model of Iontophoretic Ocular Research

Ophthalmic Research

Volumn 43, Issue 4, 2010, Pages 208-216

  Thomazini, J A ^a   Gelfuso, G M ^a   Lopez, R F V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Corneal integrity; Electron transmission microscopy; Excised porcine cornea; Iontophoresis; Ocular diffusion cell

Indexed keywords

FLUORESCEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CORNEA; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; IONTOPHORESIS; METABOLISM; PERMEABILITY; SURFACE PROPERTY; SWINE; TRANSMISSION ELECTRON MICROSCOPY; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANIMALS; BIOLOGICAL TRANSPORT; CORNEA; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; FLUORESCEIN; IONTOPHORESIS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; PERMEABILITY; SURFACE PROPERTIES; SWINE;

EID: 73649134378     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000274494     Document Type: Article

References (39)

1. Eljarrat-Binstock E, Domb AJ: Iontophoresis: A non-invasive ocular drug delivery. J Control Release 2006; 110: 479-489.
2. Gelfuso GM, Figueiredo FV, Gratieri T, Lopez RF: The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS 4 ). J Pharm Sci 2008; 97: 4249-4257.
3. Kalia YN, Naik A, Garrison J, Guy RH: Iontophoretic drug delivery. Adv Drug Deliv Rev 2004; 56: 619-658.
4. Lopez RF, Bentley MV, Delgado-Charro MB, Guy RH: Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm Res 2001; 18: 311-315.
5. Eljarrat-Binstock E, Orucov F, Aldouby Y, et al: Charged nanoparticles delivery to the eye using hydrogel iontophoresis. J Control Release 2008; 126: 156-161.
6. Zhang L, Zhang JJ, Wang LY, Xia HY: Ocular pharmacokinetics and availability of topically applied baicalein in rabbits. Curr Eye Res 2009; 34: 257-263.
7. El Kamel AH: In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm 2002; 241: 47-55.
8. Mosteller MW, Gebhardt BM, Hamilton AM, Kaufman HE: Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum. Arch Ophthalmol 1985; 103: 101-102.
9. Reichl S: Cell culture models of the human cornea-a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro. J Pharm Pharmacol 2008; 60: 299-307.
10. Jarvinen K, Jarvinen T, Urtti A: Ocular absorption following topical delivery. Adv Drug Deliv Rev 1995; 16: 3-19.
11. Majumdar S, Hingorani T, Srirangam R, et al: Transcorneal permeation of L-and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement. Pharm Res 2009; 26: 1261-1269.
12. Hornof M, Toropainen E, Urtti A: Cell culture models of the ocular barriers. Eur J Pharm Biopharm 2005; 60: 207-225.
13. Tegtmeyer S, Papantoniou I, Muller-Goymann CC: Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. Eur J Pharm Biopharm 2001; 51: 119-125.
14. Xiang CD, Batugo M, Gale DC, et al: Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport. Drug Metab Dispos 2009; 37: 992-998.
15. Zeng YJ, Yang J, Huang K, et al: A comparison of biomechanical properties between human and porcine cornea. J Biomech 2001; 34: 533-537.
16. Thiel MA, Morlet N, Schulz D, et al: A simple corneal perfusion chamber for drug penetration and toxicity studies. Br J Ophthalmol 2001; 85: 450-453.
17. Cordoba-Diaz M, Nova M, Elorza B, et al: Validation protocol of an automated in-line flow-through diffusion equipment for in vitro permeation studies. J Control Release 2000; 69: 357-367.
18. Green PG, Hinz RS, Kim A, et al: Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 1991; 8: 1121-1127.
19. Berdugo M, Valamanesh F, Andrieu C, et al: Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev 2003; 13: 107-114.
20. Frucht-Pery J, Raiskup F, Mechoulam H, et al: Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels. Cornea 2006; 25: 1182-1186.
21. Kralinger MT, Voigt M, Kieselbach GF, et al: Ocular delivery of acetylsalicylic acid by repetitive Coulomb-controlled iontophoresis. Ophthalmic Res 2003; 35: 102-110.
22. Frucht-Pery J, Mechoulam H, Siganos CS, et al: Iontophoresis-gentamicin delivery into the rabbit cornea, using a hydrogel delivery probe. Exp Eye Res 2004; 78: 745-749.
23. Glikfeld P, Cullander C, Hinz RS, Guy RH: A new system for in vitro studies of iontophoresis. Pharm Res 1988; 5: 443-446.
24. Lopez RF, Bentley MV, Delgado-Charro MB, et al: Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem Photobiol 2003; 77: 304-308.
25. Lopez RF, Bentley MV, Begona Delgado-Charro M, Guy RH: Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 2003; 88: 65-70.
26. Camber O: An in vitro model for determination of drug permeability through the cornea. Acta Pharm Suec 1985; 22: 335-342.
27. Bronaugh RL, Stewart RF: Methods for in vitro percutaneous absorption studies. IV. The flow-through diffusion cell. J Pharm Sci 1985; 74: 64-67.
28. Ashton P, Wang W, Lee VH: Location of penetration and metabolic barriers to levobunolol in the corneal epithelium of the pigmented rabbit. J Pharmacol Exp Ther 1991; 259: 719-724.
29. Vorwerk CK, Tuchen S, Streit F, et al: Aqueous humor concentrations of topically administered caspofungin in rabbits. Ophthalmic Res 2009; 41: 102-105.
30. Yee RW, Cheng CJ, Meenakshi S, et al: Ocular penetration and pharmacokinetics of topical fluconazole. Cornea 1997; 16: 64-71.
31. Toropainen E, Ranta VP, Vellonen KS, et al: Paracellular and passive transcellular permeability in immortalized human corneal epithelial cell culture model. Eur J Pharm Sci 2003; 20: 99-106.
32. Monti D, Saccomani L, Chetoni P, et al: Effect of iontophoresis on transcorneal permeation 'in vitro' of two beta-blocking agents, and on corneal hydration. Int J Pharm 2003; 250: 423-429.
33. Freeman RD, Fatt I: Environmental influences on ocular temperature. Invest Ophthalmol 1973; 12: 596-602.
34. Elaut G, Vanhaecke T, Heyden YV, Rogiers V: Spontaneous apoptosis, necrosis, energy status, glutathione levels and biotransformation capacities of isolated rat hepatocytes in suspension: effect of the incubation medium. Biochem Pharmacol 2005; 69: 1829-1838.
35. Nair V, Panchagnula R: Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide. Pharmacol Res 2003; 48: 175-182.
36. Lee VH, Carson LW, Kashi SD, Stratford RE Jr: Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits. J Ocul Pharmacol 1986; 2: 345-352.
37. Guy RH, Kalia YN, Delgado-Charro MB, et al: Iontophoresis: electrorepulsion and electroosmosis. J Control Release 2000; 64: 129-132.
38. Mathy FX, Ntivunwa D, Verbeeck RK, Preat V: Fluconazole distribution in rat dermis following intravenous and topical application: A microdialysis study. J Pharm Sci 2005; 94: 770-780.
39. Sonego-Krone S, Sanchez-Di Martino D, Ayala-Lugo R, et al: Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. Graefes Arch Clin Exp Ophthalmol 2006; 244: 782-787.